WM Technology (MAPSW) had the highest return between January 1, 2024 and January 12, 2024 by a US stock with a market cap of $2B+, returning 100%.
| ASSET | DATE | % RETURN |
|---|---|---|
WM Technology (MAPSW) | 1/1/2024 - 1/12/2024 | 100% |
Flex (FLEX) | 1/1/2024 - 1/12/2024 | 71.4% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 1/1/2024 - 1/12/2024 | 56.52% |
GeneDx (WGS) | 1/1/2024 - 1/12/2024 | 35.56% |
Keros Therapeutics (KROS) | 1/1/2024 - 1/12/2024 | 33.71% |
ZIM Integrated Shipping Services (ZIM) | 1/1/2024 - 1/12/2024 | 29.42% |
Dyne Therapeutics (DYN) | 1/1/2024 - 1/12/2024 | 28.19% |
Juniper Networks (JNPR) | 1/1/2024 - 1/12/2024 | 27.76% |
Longboard Pharmaceuticals (LBPH) | 1/1/2024 - 1/12/2024 | 26.89% |
Oscar Health (OSCR) | 1/1/2024 - 1/12/2024 | 26.8% |
Avidity Biosciences (RNA) | 1/1/2024 - 1/12/2024 | 25.83% |
Vera Therapeutics (VERA) | 1/1/2024 - 1/12/2024 | 24.67% |
Sarepta Therapeutics (SRPT) | 1/1/2024 - 1/12/2024 | 22.3% |
Super Micro Computer (SMCI) | 1/1/2024 - 1/12/2024 | 21.27% |
Uranium Energy (UEC) | 1/1/2024 - 1/12/2024 | 21.22% |
Merus (MRUS) | 1/1/2024 - 1/12/2024 | 20.21% |
Summit Therapeutics (SMMT) | 1/1/2024 - 1/12/2024 | 20.16% |
Arrowhead Pharmaceuticals (ARWR) | 1/1/2024 - 1/12/2024 | 19.44% |
Apellis Pharmaceuticals (APLS) | 1/1/2024 - 1/12/2024 | 17.26% |
Apogee Therapeutics, Inc Common Stock (APGE) | 1/1/2024 - 1/12/2024 | 16.39% |
Organon (OGN) | 1/1/2024 - 1/12/2024 | 16.16% |
Cameco (CCJ) | 1/1/2024 - 1/12/2024 | 15.96% |
Viking Therapeutics (VKTX) | 1/1/2024 - 1/12/2024 | 15.7% |
Recursion Pharmaceuticals (RXRX) | 1/1/2024 - 1/12/2024 | 15.29% |
WD-40 (WDFC) | 1/1/2024 - 1/12/2024 | 15.15% |
